Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 111-120 of 139 for Epilepsy

Edit search filters
  1. A Study to Evaluate Radio Signal Characterization of Seizures

    Rochester, MN

  2. Is physical exercise associated with significant changes in the frequency or burden of spikes on EEG in children with epilepsy?

    Rochester, MN

  3. A Study of Imaging and Systemic Markers in Patients with Epilepsy

    Rochester, MN

  4. Human Brain Mapping to Understand Mechanisms of Learning, Memory, and Cognition

    Jacksonville, FL

  5. A Study of Multicenter Outcomes in Pediatric Status Epilepticus

    Rochester, MN

  6. Biomarkers For Seizure

    Jacksonville, FL, Rochester, MN

  7. Biomarker Targeted Stimulation For Epileptiform Events

    Rochester, MN

  8. A Study of Neurophysiological and Inflammatory Biomarkers of Seizures and Brain Injury in Children

    Rochester, MN

  9. Neural Circulatory Control and SUDEP Risk.

    Rochester, MN

  10. RNS® System RESPONSE Study

    Rochester, MN

.

Mayo Clinic Footer